WHO ICTRP trial
The effect and safety of mizoribine for IgA Nephropathy in children
ChiCTR-ONC-10001124 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-ONC-10001124 |
|---|---|
| Public title | The effect and safety of mizoribine for IgA Nephropathy in children |
| Scientific title | The effect and safety of mizoribine for IgA Nephropathy in children |
| Primary sponsor | Nanjing general hospital of Nanjing military command |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | Post-market |
| Countries | China |
| Conditions | IgA nephropathy |
| Interventions | 1:mizoribine 3~5mg/kg.d |
| Registration date | Dec 4, 2010 |
| Target size | 1:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: